These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 15207941)

  • 1. Controlled lithium discontinuation in bipolar patients with good response to long-term lithium prophylaxis.
    Yazici O; Kora K; Polat A; Saylan M
    J Affect Disord; 2004 Jun; 80(2-3):269-71. PubMed ID: 15207941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study.
    Biel MG; Peselow E; Mulcare L; Case BG; Fieve R
    Bipolar Disord; 2007 Aug; 9(5):435-42. PubMed ID: 17680913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective 4-5 year follow-up of juvenile onset bipolar disorder.
    Jairam R; Srinath S; Girimaji SC; Seshadri SP
    Bipolar Disord; 2004 Oct; 6(5):386-94. PubMed ID: 15383131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up.
    Baethge C; Gruschka P; Berghöfer A; Bauer M; Müller-Oerlinghausen B; Bschor T; Smolka MN
    J Affect Disord; 2004 Apr; 79(1-3):43-50. PubMed ID: 15023479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
    Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
    J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients.
    Mur M; Portella MJ; Martínez-Arán A; Pifarré J; Vieta E
    J Clin Psychiatry; 2008 May; 69(5):712-9. PubMed ID: 18435565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term lithium prophylaxis in the bipolar affective disorder].
    Suwalska A; Chłopocka-Woźniak M; Rybakowski J
    Psychiatr Pol; 2002; 36(6 Suppl):63-9. PubMed ID: 12647423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the optimal serum lithium level in the long-term treatment of bipolar disorder--a review?
    Severus WE; Kleindienst N; Seemüller F; Frangou S; Möller HJ; Greil W
    Bipolar Disord; 2008 Mar; 10(2):231-7. PubMed ID: 18271901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Short-term sequelae of lithium discontinuation].
    Verdoux H; Bourgeois M
    Encephale; 1993; 19(6):645-50. PubMed ID: 12404784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders.
    Tondo L; Baldessarini RJ; Floris G
    Br J Psychiatry Suppl; 2001 Jun; 41():s184-90. PubMed ID: 11450181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of patients with bipolar disorder commenced on lithium prophylaxis during hospitalization: a complete 15-year register-based follow-up.
    Licht RW; Vestergaard P; Brodersen A
    Bipolar Disord; 2008 Feb; 10(1):79-86. PubMed ID: 18199244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication use patterns and 2-year outcome in first-admission bipolar disorder with psychotic features.
    Craig TJ; Grossman S; Mojtabai R; Gibson PJ; Lavelle J; Carlson GA; Bromet EJ
    Bipolar Disord; 2004 Oct; 6(5):406-15. PubMed ID: 15383133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bouncing back: is the bipolar rebound phenomenon peculiar to lithium? A retrospective naturalistic study.
    Franks M; Macritchie KA; Mahmood T; Young AH
    J Psychopharmacol; 2008 Jun; 22(4):452-6. PubMed ID: 18635725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inositol augmentation of lithium or valproate for bipolar depression.
    Eden Evins A; Demopulos C; Yovel I; Culhane M; Ogutha J; Grandin LD; Nierenberg AA; Sachs GS
    Bipolar Disord; 2006 Apr; 8(2):168-74. PubMed ID: 16542187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selecting appropriate treatments for maintenance therapy for bipolar disorder.
    Thase ME
    J Clin Psychiatry; 2008; 69 Suppl 5():28-35. PubMed ID: 19265638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMPI as a measure of subthreshold and residual psychopathology among the offspring of lithium responsive and non-responsive bipolar parents.
    Demidenko N; Grof P; Alda M; Deshauer D; Duffy A
    Bipolar Disord; 2004 Aug; 6(4):323-8. PubMed ID: 15225151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
    Mazza M; Mandelli L; Di Nicola M; Harnic D; Catalano V; Tedeschi D; Martinotti G; Colombo R; Bria P; Serretti A; Janiri L
    J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for neuroleptics in bipolar depression?
    Hendrick V; Altshuler LL; Szuba MP
    J Clin Psychiatry; 1994 Dec; 55(12):533-5. PubMed ID: 7814347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of restarting lithium treatment after its discontinuation in bipolar I and bipolar II disorders.
    Tondo L; Baldessarini RJ; Floris G; Rudas N
    Am J Psychiatry; 1997 Apr; 154(4):548-50. PubMed ID: 9090344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.